HNB
TEVA icon

Huntington National Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Huntington National Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
8,001
-269
-3% -$8.96K ﹤0.01% 823
2026
Q1 		$249K Buy
8,270
+555
+7% +$17.9K ﹤0.01% 790
2025
Q4 		$241K Sell
7,715
-524
-6% -$12.9K ﹤0.01% 707
2025
Q3 		$166K Sell
8,239
-1,870
-18% -$32.8K ﹤0.01% 824
2025
Q2 		$169K Buy
10,109
+2,921
+41% +$47.1K ﹤0.01% 795
2025
Q1 		$110K Buy
7,188
+1,308
+22% +$23.4K ﹤0.01% 885
2024
Q4 		$130K Buy
5,880
+2,317
+65% +$42.2K ﹤0.01% 845
2024
Q3 		$64.2K Sell
3,563
-100
-3% -$1.75K ﹤0.01% 1087
2024
Q2 		$59.5K Buy
3,663
+26
+0.7% +$400 ﹤0.01% 1050
2024
Q1 		$51.3K Hold
3,637
– – ﹤0.01% 1119
2023
Q4 		$38K Sell
3,637
-8
-0.2% -$75 ﹤0.01% 1182
2023
Q3 		$37.2K Hold
3,645
– – ﹤0.01% 1140
2023
Q2 		$27.4K Sell
3,645
-524
-13% -$4.25K ﹤0.01% 1261
2023
Q1 		$36.9K Buy
4,169
+532
+15% +$5.26K ﹤0.01% 1106
2022
Q4 		$33.2K Hold
3,637
– – ﹤0.01% 1119
2022
Q3 		$29K Buy
3,637
+36
+1% +$318 ﹤0.01% 1155
2022
Q2 		$26K Hold
3,601
– – ﹤0.01% 1228
2022
Q1 		$33K Sell
3,601
-1,249
-26% -$10.4K ﹤0.01% 1200
2021
Q4 		$38K Buy
4,850
+2,601
+116% +$23.5K ﹤0.01% 1164
2021
Q3 		$22K Buy
2,249
+1,000
+80% +$9.36K ﹤0.01% 1226
2021
Q2 		$12K Sell
1,249
-1,000
-44% -$10.6K ﹤0.01% 1418
2021
Q1 		$26K Hold
2,249
– – ﹤0.01% 1052
2020
Q4 		$22K Sell
2,249
-225
-9% -$2.16K ﹤0.01% 1098
2020
Q3 		$22K Buy
2,474
+174
+8% +$1.84K ﹤0.01% 1024
2020
Q2 		$28K Hold
2,300
– – ﹤0.01% 929
2020
Q1 		$20K Sell
2,300
-2,324
-50% -$23.8K ﹤0.01% 1036
2019
Q4 		$45K Buy
4,624
+1,294
+39% +$11.6K ﹤0.01% 984
2019
Q3 		$23K Sell
3,330
-185
-5% -$1.42K ﹤0.01% 1084
2019
Q2 		$33K Sell
3,515
-165
-4% -$1.99K ﹤0.01% 984
2019
Q1 		$57K Buy
3,680
+1,725
+88% +$30.4K ﹤0.01% 821
2018
Q4 		$30K Sell
1,955
-858
-31% -$17.6K ﹤0.01% 1009
2018
Q3 		$61K Sell
2,813
-528
-16% -$12.3K ﹤0.01% 883
2018
Q2 		$82K Sell
3,341
-1,290
-28% -$26.3K ﹤0.01% 794
2018
Q1 		$79K Sell
4,631
-1,118
-19% -$21.8K ﹤0.01% 823
2017
Q4 		$109K Sell
5,749
-5,606
-49% -$84.3K ﹤0.01% 747
2017
Q3 		$199K Sell
11,355
-7,545
-40% -$170K ﹤0.01% 570
2017
Q2 		$628K Sell
18,900
-2,164
-10% -$67K 0.01% 403
2017
Q1 		$676K Sell
21,064
-7,325
-26% -$250K 0.01% 411
2016
Q4 		$1.03M Sell
28,389
-10,680
-27% -$426K 0.02% 350
2016
Q3 		$1.8M Sell
39,069
-15,348
-28% -$801K 0.03% 287
2016
Q2 		$2.73M Sell
54,417
-21,908
-29% -$1.17M 0.07% 212
2016
Q1 		$4.76M Buy
76,325
+6,175
+9% +$362K 0.12% 172
2015
Q4 		$4.61M Buy
70,150
+249
+0.4% +$15.4K 0.12% 176
2015
Q3 		$3.95M Sell
69,901
-4,048
-5% -$262K 0.1% 187
2015
Q2 		$4.37M Sell
73,949
-2,376
-3% -$147K 0.11% 187
2015
Q1 		$4.76M Sell
76,325
-7,446
-9% -$433K 0.12% 174
2014
Q4 		$4.82M Sell
83,771
-4,589
-5% -$256K 0.12% 179
2014
Q3 		$4.75M Buy
88,360
+4,957
+6% +$263K 0.1% 210
2014
Q2 		$4.37M Sell
83,403
-1,586
-2% -$81.1K 0.09% 250
2014
Q1 		$4.49M Sell
84,989
-2,787
-3% -$129K 0.09% 268
2013
Q4 		$3.52M Sell
87,776
-18,069
-17% -$711K 0.09% 190
2013
Q3 		$4M Sell
105,845
-50,786
-32% -$1.98M 0.12% 169
2013
Q2 		$6.14M Buy
+156,631
New +$6.1M 0.19% 127

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Huntington National Bank's TEVA Position: Q2 2026 in Review

Huntington National Bank reduced its Teva Pharmaceuticals (TEVA) stake by 3.3% in Q2 2026, selling an estimated $8.96K and leaving 8,001 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Huntington National Bank first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.14M in Q2 2013. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Huntington National Bank held 8,001 shares of Teva Pharmaceuticals worth $271K as of Q2 2026.
  • Huntington National Bank sold 269 Teva Pharmaceuticals shares in Q2 2026, an estimated $8.96K.
  • Teva Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #823 holding.
  • Huntington National Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Huntington National Bank's Teva Pharmaceuticals position peaked at $6.14M in Q2 2013.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.